Backs the trader's plan to initiate half the target size immediately — the 200 SMA is rising, the 10 EMA has been reclaimed, and the risk/reward to the real target of $287.20 (not just $256) is over 3.5R against the $244.30 stop.
Argues waiting for a confirmed close above $256 just means chasing the move at a worse price; the defined $244.30 stop already does the risk-management work.
Agrees the direction is right but calls half size into an unconfirmed bounce, directly under a resistance cluster ($254–256), too aggressive — the near-term risk/reward to the first target is under 1R.
Proposes one-third now at $253.70, stop below $244.30, add another third on $256 + MACD confirmation, optional final third on continued strength, capped at 100% of standard until confirmation.
Calls this a two-day bounce, not a confirmed reversal — price remains below the 50 SMA, VWMA and Bollinger mid, FCF is nearly nonexistent, and the Nov 3 midterms bring near-term regulatory risk, not a 2027 story.
Wants a 25% starter position only, no adds until a daily close above $256 with MACD crossover and a VWMA reclaim, and the total capped at 100% of standard — no 110–120% concentration.
Thesis: All three risk analysts converged on the same directional call — accumulate AMZN — and disagreed only on execution. The fundamentals engine is unambiguous and strengthening: $139.5B TTM operating cash flow growing 20% YoY, revenue re-accelerating to 16.6% from 12.4%, record 13.1% operating margins, and net debt of just $17.3B against $143B cash on a $2.7T market cap (~30x interest coverage). But earnings-quality distortion (forward EPS $10.38 below TTM $12.43), a genuine FCF trough (TTM FCF $3.2B), a hawkish macro backdrop (96% odds of no 2026 rate cuts), and imminent election-driven regulatory risk (Democrats 92%/60% House/Senate odds ahead of the Nov 3 midterms) keep this short of a full-size Buy. Technically, the long-term anchor is intact — 200 SMA $240.30 and rising, price 5.6% above it — with an early but real momentum turn (10 EMA reclaimed, RSI 39.4→48.0, MACD histogram decelerating).
Action: accumulate in stages. Initiate roughly one-third to one-half of target size at current levels (~$253.70) with a hard exit on a confirmed daily close below $244.30. Add only on a daily close above $256 with a MACD bullish crossover (never on a $256 break without MACD confirmation — bull-trap risk), targeting $258–260, then $265.88, then the 52-week high at $287.20. Never add below $244.30 under any circumstances; a decisive break of the $240.30 200-day SMA is full invalidation. Cap the position at 100% of a standard allocation until confirmation, extending toward ~110–120% only if the late-October earnings call signals capex peaking or an FCF inflection — that call is the first major checkpoint on this thesis.